SM
CLMT icon

SG3 Management’s Calumet Specialty Products CLMT Stock Holding History

SG3 Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-267,900
Closed -$3.54M – 1019
2021
Q4 		$3.54M Buy
+267,900
New +$3.37M 0.07% 246

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG3 Management's CLMT Position: Q1 2022 in Review

SG3 Management sold out of Calumet Specialty Products (CLMT) in Q1 2022, closing a stake of 169,625 shares — an estimated $2.24M sold.

SG3 Management first reported a position in CLMT in Q2 2021 and held it in 2 quarters. The position peaked at $2.24M in Q4 2021. 61 funds tracked by Wall St. Rank hold CLMT as of Q1 2022.

  • SG3 Management reported no remaining Calumet Specialty Products position as of Q1 2022 after selling out during the quarter.
  • SG3 Management sold 169,625 Calumet Specialty Products shares in Q1 2022, an estimated $2.24M.
  • SG3 Management first reported a position in Calumet Specialty Products in Q2 2021 and held it in 2 quarters.
  • SG3 Management's Calumet Specialty Products position peaked at $2.24M in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.